This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC completed the acquisition of Renal Business from Cantel Medical LLC. CI
Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC entered into a definitive agreement to acquire Renal Business from Cantel Medical LLC for approximately $200 million. CI
Azek : Hires Peter Clifford for CFO Role MT
Cantel Medical Corp. Announces Board Changes CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 1000 CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Composite 1500 CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Healthcare Equipment Select Industry Index CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 400 Health Care CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P 400 CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P Global BMI Index CI
Cantel Medical Corp.(NYSE:CMD) dropped from S&P TMI Index CI
STERIS plc completed the acquisition of Cantel Medical Corp. from Charles M. Diker, Mark N. Diker, Diker Management LLC, Champlain Investment Partners, LLC, Brown Capital Management, LLC and others. CI
Cantel Medical Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2021 CI
Crocs : to Replace Cantel Medical in S&P MidCap 400, Organogenesis Moves to S&P SmallCap 600 MT
STERIS : Needham Upgrades STERIS to Buy From Hold, Citing Cantel Medical Deal; Sets $233 Price Target MT
Steris : Positioned to Beat FY22 Estimates on Conservative Guidance After Q4 Shortfall, Says Needham MT
Steris : Poised to see Stable Revenue Growth of 4%-6% in Fiscal 2022, Needham says MT
STERIS : Sees Higher Fiscal 2021 Revenue MT
Cantel Medical : Fiscal Q2 Results Lead Needham to Raise EPS, Revenue Estimates MT
Transcript : Cantel Medical Corp., Q2 2021 Earnings Call, Mar 09, 2021
Cantel Medical : Fiscal Q2 Adjusted Earnings, Revenue Rise MT
STERIS : Earnings Flash (STE) CANTEL MEDICAL Reports Q2 Revenue $294M, vs. Street Est of $276.6M MT
STERIS : Earnings Flash (STE) CANTEL MEDICAL Posts Q2 EPS $0.79, vs. Street Est of $0.50 MT
Cantel Medical Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended January 31, 2021 CI
CANTEL MEDICAL : Needham Downgrades Cantel Medical to Hold From Buy MT
Chart Cantel Medical Corp.
More charts
Cantel Medical LLC is a United States-based company that provides infection prevention solutions. The Company provides infection prevention products and services for patients, caregivers and other healthcare providers. Its operates through three primary segments, such as Medical, Dental and Life Sciences.
More about the company
  1. Stock Market
  2. Equities
  3. CMD Stock
  4. News Cantel Medical Corp.
  5. Cantel Medical : Fiscal Q2 Results Lead Needham to Raise EPS, Revenue Estimates